Century Therapeutics (IPSC) Cash & Equivalents (2020 - 2026)
Century Therapeutics' (IPSC) quarterly Cash & Equivalents came in at $51.0 million in Q1 2026, down 1.58% year-on-year from $51.9 million in Q1 2025, and down 54.94% on a QoQ basis from $113.3 million in Q4 2025.
Century Therapeutics (IPSC) Cash & Equivalents (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has 7 years of Cash & Equivalents data on file, last reported at $51.0 million in Q1 2026.
- On a quarterly basis, Cash & Equivalents fell 1.58% year-over-year to $51.0 million in Q1 2026; TTM through Mar 2026 was $51.0 million, a 1.58% decrease from a year earlier, with the FY2025 full-year figure at $113.3 million, up 93.86% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $51.0 million, down from $113.3 million in the prior quarter.
- Over the last five years, Cash & Equivalents for IPSC reached as high as $126.0 million in Q1 2022 and fell as low as $41.5 million in Q2 2024.
- Historically, Cash & Equivalents has averaged $71.5 million across 5 years, with a median of $56.9 million in 2025.
- Across the five-year window, Cash & Equivalents plunged 58.58% in 2022 and jumped 93.86% in 2025, its largest moves.
- Year by year, Cash & Equivalents stood at $84.3 million in 2022, then tumbled by 43.84% to $47.3 million in 2023, then gained by 23.49% to $58.4 million in 2024, then soared by 93.86% to $113.3 million in 2025, then slumped by 54.94% to $51.0 million in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $51.0 million in Q1 2026, $113.3 million in Q4 2025, and $55.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 82.45 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.49 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 3.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 440.94 Mn |
| 10 | Century Therapeutics | 419.84 Mn | 285.04 Mn | - | 51.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.05 Mn |
| Dec 31, 2025 | 113.29 Mn |
| Sep 30, 2025 | 55.52 Mn |
| Jun 30, 2025 | 56.88 Mn |
| Mar 31, 2025 | 51.87 Mn |
| Dec 31, 2024 | 58.44 Mn |
| Sep 30, 2024 | 52.59 Mn |
| Jun 30, 2024 | 41.46 Mn |
| Mar 31, 2024 | 46.81 Mn |
| Dec 31, 2023 | 47.32 Mn |
| Sep 30, 2023 | 55.31 Mn |
| Jun 30, 2023 | 64.44 Mn |
| Mar 31, 2023 | 86.83 Mn |
| Dec 31, 2022 | 84.27 Mn |
| Sep 30, 2022 | 111.35 Mn |
| Jun 30, 2022 | 112.79 Mn |
| Mar 31, 2022 | 126.04 Mn |
| Dec 31, 2021 | 56.45 Mn |
| Sep 30, 2021 | 101.29 Mn |
| Jun 30, 2021 | 272.28 Mn |